Chemopreventive effect of squalene on colon cancer

被引:256
作者
Rao, CV
Newmark, HL
Reddy, BS
机构
[1] Amer Hlth Fdn, Div Nutr Carcinogenesis, Valhalla, NY 10595 USA
[2] Rockefeller Univ, Strang Canc Res Lab, New York, NY 10021 USA
关键词
D O I
10.1093/carcin/19.2.287
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epidemiologic and laboratory studies suggest a cancer protective effect and/or lack of a tumor promoting effect by dietary olive oil as compared with other types of non-marine oils. Squalene, a constituent of olive oh, and a key intermediate in cholesterol synthesis may be regarded as partially responsible for the beneficial effects of olive oil, which include decreased mortality rates among populations with high olive oil consumption. Thus, in this study we have assessed the chemopreventive efficacy of squalene on azoxymethane (AOM)-induced colonic aberrant crypt foci (ACF). In addition, we measured the effect of squalene on serum cholesterol levels in the rats, Male F34 rats (5 weeks old) were fed the control diet (modified AIN-76A) or experimental diets containing 1% squalene or 320 p.p.m. sulindac, two weeks later, all animals except those in vehicle (normal saline)-treated groups were s,c, injected with AOM (15 mg/kg body wt, once weekly for 2 weeks). At 16 weeks of age, all rats mere killed, colons were evaluated for ACF and serum was assayed for the cholesterol levels. As expected, dietary administration of sulindac suppressed ACF development and reduced crypt multiplicity, i.e. number of aberrant crypts/focus. Administration of dietary squalene inhibited total ACF induction and crypt multiplicity by similar to>46% (P < 0.001). Further, squalene at a level of 1% did not show any significant effect on serum cholesterol levels. Our finding that squalene significantly suppresses colonic ACF formation and crypt multiplicity strengthens the hypothesis that squalene possesses chemopreventive activity against colon carcinogenesis.
引用
收藏
页码:287 / 290
页数:4
相关论文
共 40 条
[1]  
ALLAIN CC, 1974, CLIN CHEM, V20, P470
[2]  
COHEN LA, 1986, JNCI-J NATL CANCER I, V77, P33
[3]  
GERBER M, 1991, MEDITERRANEAN DIET C
[4]   TREATMENT OF COLONIC AND RECTAL ADENOMAS WITH SULINDAC IN FAMILIAL ADENOMATOUS POLYPOSIS [J].
GIARDIELLO, FM ;
HAMILTON, SR ;
KRUSH, AJ ;
PIANTADOSI, S ;
HYLIND, LM ;
CELANO, P ;
BOOKER, SV ;
ROBINSON, CR ;
OFFERHAUS, GJA .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (18) :1313-1316
[5]   REGULATION OF THE MEVALONATE PATHWAY [J].
GOLDSTEIN, JL ;
BROWN, MS .
NATURE, 1990, 343 (6257) :425-430
[6]  
IKIKAWA T, 1986, J PHARM SOC JPN, V106, P578
[7]  
JEN J, 1994, CANCER RES, V54, P5523
[8]   ISOPRENOID ADDITION TO RAS PROTEIN IS THE CRITICAL MODIFICATION FOR ITS MEMBRANE ASSOCIATION AND TRANSFORMING ACTIVITY [J].
KATO, K ;
COX, AD ;
HISAKA, MM ;
GRAHAM, SM ;
BUSS, JE ;
DER, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (14) :6403-6407
[9]  
KOHL NE, 1995, J CELL BIOCHEM, P145
[10]   SQUALENE FEEDING IN EXPERIMENTAL ATHEROSCLEROSIS [J].
KRITCHEVSKY, D ;
MOYER, AW ;
TESAR, WC ;
LOGAN, JB ;
BROWN, RA ;
RICHMOND, G .
CIRCULATION RESEARCH, 1954, 2 (04) :340-343